U.S. markets closed

AngioDynamics, Inc. (ANGO)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD.
Añadir a la lista de seguimiento
6.27+0.19 (+3.13%)
Al cierre: 04:00PM EDT
6.29 +0.02 (+0.32%)
Fuera de horario: 04:38PM EDT

AngioDynamics, Inc.

14 Plaza Drive
Latham, NY 12110
United States
518 795 1400
https://www.angiodynamics.com

Sector(es)Healthcare
IndustriaMedical Instruments & Supplies
Empleados a tiempo completo815

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. James C. ClemmerCEO, President & Director982.92kN/D1964
Mr. Stephen A. TrowbridgeExecutive VP & CFO528.02k79.25k1974
Mr. Chad T. CampbellSenior VP and GM of Global Vascular Access & Oncology Global Business Unit416.51kN/D1971
Ms. Laura PiccininiSenior VP & GM of International444.31kN/D1969
Mr. Saleem M. CheeksVice President of CommunicationsN/DN/DN/D
Mr. Benjamin H. DavisSenior Vice President of Business DevelopmentN/DN/D1964
Ms. Marna I. Bronfen-MooreSenior Vice President of Human ResourcesN/DN/D1967
Mr. Warren G. NighanSenior Vice President of Quality & Regulatory Affairs622.11kN/D1969
Ms. Kim L. SeaburySenior Vice President of Information TechnologyN/DN/D1967
Mr. Juan Carlos SernaSenior Vice President of Scientific & Clinical AffairsN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Gestión corporativa

La calificación ISS Governance QuickScore de AngioDynamics, Inc. a partir del 1 de mayo de 2024 es 4. Las puntuaciones principales son Auditoría: 9; Junta: 3; Derechos del accionista: 6; Compensación: 3.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.